The implications of supraphysiological testosterone supplementation
The Journal of Sexual Medicine · 2024
DOI: 10.1093/jsxmed/qdad179 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Sexual Medicine, 2024. Verfasst von Alice T Chu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Emory University School of Medicine, Atlanta, GA 30332, United States. Hauptthemen laut MEDLINE: Testosterone, Hypogonadism. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Testosterone deficiency is common among aging men and causes a variety of sexual, psychological, and physical symptoms. The popularity of hormone replacement with steroids such as testosterone is relatively recent, with most literature on its effect, appropriate use, and risks published in the past 30 years. Professional society guidelines do recommend treating low testosterone in the presence of symptoms or signs of hypogonadism. Both the American Urological Association and European Academy of Andrology recommend testosterone replacement therapy to treat symptomatic testosterone deficiency, with a target testosterone level in the midnormal range. While the absolute numbers in this range may differ depending on the laboratory, the middle tertile is commonly agreed to be within the 450-600 ng/dL range. There is high-quality evidence to support testosterone correction to the eugonadal range: this range is viable for all age groups of men, and levels in this range usually ameliorate symptoms of testosterone deficiency. The TTrials, published in 2018, were a coordinated set of seven placebo-controlled, double-blind trials that investigated the efficacy of increasing testosterone levels in men with unequivocally low testosterone, and included the Sexual Function, Physical Function, Vitality, Cognitive Function, Anemia, Bone, and Cardiovascular trials. The median age of men in these trials was 72 years. All men had a baseline testosterone concentration of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Emory University School of Medicine, Atlanta, GA 30332, United States.
Zitieren
APA
Chu, A. T., & Mehta, A. (2024). The implications of supraphysiological testosterone supplementation. The Journal of Sexual Medicine. https://doi.org/10.1093/jsxmed/qdad179
Vancouver
Chu AT, Mehta A. The implications of supraphysiological testosterone supplementation. The Journal of Sexual Medicine. 2024. doi:10.1093/jsxmed/qdad179
BibTeX
@article{Chu2024,
author = {Chu, Alice T and Mehta, Akanksha},
title = {The implications of supraphysiological testosterone supplementation},
journal = {The Journal of Sexual Medicine},
year = {2024},
doi = {10.1093/jsxmed/qdad179}
}
EUVIMED